SHZ · —

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) Stock

$15.36 +1.92% SHZ: 002603.SZ —

—

Valuation

MetricValue
Price$15.36
Market Cap$26.55B
P/E Ratio19.14
P/B Ratio2.43
P/S Ratio3.38
EPS (TTM)$0.82
52-Week High$21.58
52-Week Low$14.22
Dividend Yield5.03%

Financials & Margins

MetricValue
ROE12.62%
ROA7.49%
ROCE—
Gross Margin65.17%
Operating Margin24.24%
Net Margin17.49%
Debt/Equity0.00
Current Ratio2.20

Latest News

AcadeMedia AB (FRA:V8T) (Q4 2026) Earnings Call Highlights: Record Sales and Margin Expansion ... GuruFocus.com · Aug 31, 2026 Skyhigh Security Appoints Anthony Palladino as Chief Operating Officer to Accelerate Growth GlobeNewswire · Aug 31, 2026 GIGABYTE Highlights What Drew Gamers at Gamescom 2026 with AORUS INFINITY and Immersive Gaming Experiences PR Newswire · Aug 31, 2026 ESI Named ENR's 2026 Intermountain Contractor of the Year PR Newswire · Aug 31, 2026 Outmarket AI Launches Comprehensive Employee Benefits Capabilities to Automate Manual Broker Workflows PR Newswire · Aug 31, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio11.26
EV / EBITDA10.59
FCF Yield—
Quick Ratio1.54
Interest Coverage—
Return 1Y-4.19%
Return 3Y-23.78%
Return 5Y11.23%

Ownership

Insiders Held55.92%
Institutions Held4.72%
Institutions Float Held10.70%

About Shijiazhuang Yiling Pharmaceutical Co., Ltd.

—

Shijiazhuang Yiling Pharmaceutical Co., Ltd. is led by CEO Xiang Jun Wu, employs 11,343 people, headquartered in Shijiazhuang, CN, publicly traded since 2011.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) stock trades at $15.36 with a market capitalization of $26.55B. The stock is valued at a price-to-earnings (P/E) ratio of 19.14, price-to-book of 2.43, price-to-sales of 3.38. Over the past 52 weeks the stock has ranged between $14.22 and $21.58, and currently trades 28.8% below its 52-week high. It pays a dividend yielding 5.03%.

On profitability, Shijiazhuang Yiling Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 12.62%, an operating margin of 24.24%, a net profit margin of 17.49%.

The balance sheet shows a debt-to-equity ratio of 0.00 (debt below half of shareholders' equity), a current ratio of 2.20.

002603.SZ has an average daily trading volume of 25,255,791 shares, a beta of 0.47 (historically less volatile than the overall market), 1.67B shares outstanding.

Official website: www.yiling.cn

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) — frequently asked questions

What is Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) stock price today?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) is currently trading at $15.36, up 1.92% today.

What is 002603.SZ P/E ratio?

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s P/E ratio is 19.14. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is 002603.SZ return on equity (ROE)?

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s return on equity (ROE) is 12.62%. ROE measures net income relative to shareholders' equity. This is within the typical market range of roughly 12-15%.

What is Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s market cap?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. has a market capitalization of $26.55B.

Does 002603.SZ pay a dividend?

Yes. Shijiazhuang Yiling Pharmaceutical Co., Ltd. currently yields 5.03%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does 002603.SZ carry?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.00. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 002603.SZ's profit margin?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. reports a net profit margin of 17.49% — the share of revenue left after every cost, including tax and interest.

What sector is 002603.SZ in?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 002603.SZ listed on?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002603.SZ.

What is 002603.SZ's 52-week range?

Over the last year Shijiazhuang Yiling Pharmaceutical Co., Ltd. has traded between $14.22 and $21.58.

Related — Stocks

BSP Bending Spoons S.p.A. $46.63 +5.78% MAIR Madison Air Solutions Corporation $22.92 +0.70% USDE StablecoinX Inc. $1.00 -0.01% LFTO Liftoff Mobile, Inc. $16.75 +0.36% HBNB Hotel101 Global Holdings Corp. $4.42 -8.45% LCLN Lincoln International, Inc. $23.44 -0.34% FCBM First Carolina Financial Services, Inc. $12.93 -0.08% EFTY Etoiles Capital Group Co., Ltd. $15.02 +0.00% HCHL Happy City Holdings Limited $3.96 +0.00% XLAB Exascale Labs Holdings Inc. $3.39 +1.19% EXYN Exyn Technologies, Inc. $2.94 +0.34%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 002603.SZ currently matches

On the figures above, Shijiazhuang Yiling Pharmaceutical Co., Ltd. passes the filters for 22 of our ready-made screens, among them High Dividend Stocks, Dividend Stocks, Low Debt Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

High Dividend StocksDividend StocksLow Debt Dividend StocksS&P 500 Dividend StocksLow Debt StocksLarge Cap StocksFree Stock Screener PicksStocks With PE Under 20Debt Free Stocks Under $100Large Cap High Dividend StocksDividend Yield Over 5%Debt Free StocksHigh Margin Dividend StocksStocks Under $100Stocks Under $50High Gross Margin StocksLarge Cap Dividend StocksDividend Yield Over 3%Stocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.